Tuesday’s Piece: FDA Recalls Certain Versions of Extended Release Metformin Due to NDMA Levels

Due to the increased levels of N-nitrosodimethylamine (NDMA) found in extended release metformin, FDA recommends a voluntary recall of certain extended release versions of metformin. NDMA exposure at higher levels for long periods of time is associated with potential for causing cancer. Please click below for additional details.

https://www.medscape.com/viewarticle/931361?nlid=135750_3901&src=wnl_newsalrt_200529_MSCPEDIT&uac=293412PG&impID=2399725&faf=1

Online pharmacy finds high levels of NDMA in metformin
FDA releases updated COVID-19 food safety guidelines | New Hope ...

This image has an empty alt attribute; its file name is image-6.jpeg

Please share your thoughts and subscribe to receive my blogs.

#metformin #FDA #recall

Follow me on Twitter and Facebook @ReecesPiecesDi and Instagram.

Leave a Reply

Your email address will not be published. Required fields are marked *